News

Call for Abstracts:Biobanking sample and data management: Automation and best practice

Off

Why not submit an abstract to the upcoming ‘Biobanking sample and data management: Automation and best practice’ meeting

  • Deadline for abstracts to be considered for oral presentation: November 10th 2013
  • Deadline for abstracts to be considered for poster presentation: Up to 2 weeks before the event
You can download the instructions for authors at

Please see the following link for more information:

www.regonline.co.uk/bankauto2014

Abstracts can be submitted to: abstracts@euroscicon.com

When: Tuesday 18th February 2014

Where:

Cineworld: The O2
Peninsula Square
London
SE100DX
United Kingdom

What: This new event will discuss all aspects of sample and data management within the biobanking sector. Looking at automation protocols and equipment, use of IT and obtaining and maintaining ethical consent, this will bring together biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to establish best methods for effective management of biospecimens

This event has CPD accreditation and is part of BioBanking 2014 – www.biobanking2014.com

Who Should Attend: Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students, Technical Staff

Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Researchers.

Private Biobank Staff and Managers from the following departments: research and development, biobanking, biorepository, biological sample management, pharmacogenomics, pathology, genomics, translational medicine, personalised medicine, lab management, inventory management, molecular technologies, biologics research, data privacy/protection/security officers, quality control and quality management

Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: https://developer.twitter.com/en/portal/product